You are here
Crinetics Pharmaceuticals to Present at SVB Leerink Global Healthcare Conference
SAN DIEGO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced that Scott Struthers, Ph.D., Founder and Chief Executive Officer, will present at the 8th Annual SVB Leerink Global Healthcare Conference on Thursday, February 28, 2019 at 1 p.m. ET (10 a.m. PT) at the Lotte New York Palace in New York City.
Thursday, February 21, 2019 - 07:30